Source: International Congress 2016 – Translational studies in lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Chiara Cipollina (Palermo, Italy), Chiara Cipollina, Serena Di Vincenzo, Liboria Siena, Caterina Di Sano, Mark Gjomarkaj, Elisabetta Pace. The electrophilic 17-oxo-DHA enhances the anti-inflammatory efficacy of fluticasone propionate in COPD patients. Eur Respir J 2016; 48: Suppl. 60, 919

Member's Comments

No comment yet.

Related content which might interest you: The electrophilic 17-oxo-docosahexaenoic acid (17-oxo-DHA) enhances the anti-inflammatory potency of fluticasone propionate Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Enhanced anti-inflammatory gene expression in humans following inhaled budesonide Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Antiinflammatory properties of PAH drugs Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 The effect of budesonide on TLR expression in alveolar macrophages from smokers Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Simvastatin suppresses the activity of Th2 and Tc2 cells in atopic asthma and in COPD Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Elevated GM-CSF in COPD may drive defective macrophage phenotype Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Fluticasone propionate reduces influenza infection of human macrophages Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Effect of ambroxol and beclomethasone on LPS/TNF-alpha-induced neutrophil-related chemokines and nitrative stress in human bronchial epithelial cells Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Cytokine-induced glucocorticoid resistance: Effect on GILZ expression and reversal by formoterol Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Oxidative stress drives defective efferocytosis in COPD M2-like macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Tiotropium and olodaterol exert anti-proliferative effects on pulmonary fibroblasts of asthmatic patients in vitro Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Nrf2-dependent and -independent cytoprotective actions of the electrophilic Cox-2-derived 17-oxo-DHA in human macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Impaired monocyte chemotaxis in COPD Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 T regulatory cells: Immunomodulation by budesonide and formoterol on COPD patients Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Long-term effect of salmeterol and fluticasone propionate on β2-integrin mediated adhesion of neutrophils: role of annexin-1 in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006